Cardinal Health 2011 Annual Report Download - page 29

Download and view the complete annual report

Please find page 29 of the 2011 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 122

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122

B
randed manufacturer margin refers to compensation amounts under distribution service agreements wit
h
m
anu
f
acturers an
d
to p
h
armaceut
i
ca
l
pr
i
ce apprec
i
at
i
on. Amounts earne
d
un
d
er t
h
e
di
str
ib
ut
i
on serv
i
c
e
a
g
reements compensate us for a ran
g
e of distribution and related services we provide to manufacturers and
c
onsist of a fee based on volume with or without
p
harmaceutical
p
rice a
pp
reciation. In addition, a
m
anu
f
acturer may
i
ncrease
i
ts pu
bli
s
h
e
d
pr
i
ce
f
or a pro
d
uct a
f
ter we
h
ave purc
h
ase
d
t
h
at pro
d
uct
f
or
i
nventor
y
. Our contract price for branded pharmaceutical products to customers is based on th
e
m
anufacturer’s published price at the time of sale. As such, inventory sold following a manufacturer pric
e
i
ncrease w
ill b
e
b
ase
d
on t
h
e
hi
g
h
er manu
f
acturer pr
i
ce.
P
harmaceutical price appreciation refers to amounts we earn from selling inventory at these increased
pr
i
ces
.
Generic manufacturer margin (also referred to as “generic margin”) refers to price discounts, rebates and
ot
h
er
i
ncent
i
ves we rece
i
ve
f
rom manu
f
acturers o
f
gener
i
cp
h
armaceut
i
ca
l
s. Our earn
i
ngs on gener
i
c
pharmaceuticals are
g
enerall
y
hi
g
hest durin
g
the period immediatel
y
followin
g
the initial launch of a
generic product because generic pharmaceutical selling prices tend to decline over time, although this may
v
ar
y
.
Bulk and Non-bulk
S
ales. The Pharmaceutical segment differentiates between bulk and non-bulk sales based
o
nt
h
e nature o
f
our customers’ operat
i
ons. Bu
lk
sa
l
es cons
i
st o
f
sa
l
es to reta
il
c
h
a
i
n customers’ centra
li
ze
d
warehouse operations and customers’ mail order businesses. All other sales, includin
g
all sales to customer
s
l
ocated in China, are classified as non-bulk. Sales to a retail chain pharmacy customer are classified as bulk sale
s
w
i
t
h
respect to
i
ts ware
h
ouse operat
i
ons an
d
non-
b
u
lk
sa
l
es w
i
t
h
respect to
i
ts reta
il
stores. We
f
ormer
l
yre
f
erre
d
to bulk sales as bulk customers and non-bulk sales as non-bulk customers. Other than this chan
g
e in terminolo
gy,
we have not changed how we categorize revenue, segment expenses and segment profit with respect to our bul
k
a
n
d
non-
b
u
lk
sa
l
es.
S
ubstantially all bulk sales consist of products shipped in the same form that we receive them from th
e
manu
f
acturer; a sma
ll
port
i
on o
fb
u
lk
sa
l
es are
b
ro
k
en
d
own
i
nto sma
ll
er un
i
ts pr
i
or to s
hi
pp
i
ng. In contrast,
non-bulk sales require more complex servicin
g
. For non-bulk sales, we ma
y
receive inventor
y
in lar
g
e or full
case quantities and break it down into smaller quantities, warehouse the product for a longer period of time, pic
k
i
n
di
v
id
ua
l
pro
d
ucts spec
ifi
c to a customer’s or
d
er, an
dd
e
li
ver t
h
at sma
ll
er or
d
er to a customer
l
ocat
i
on
.
B
ulk sales generate significantly lower segment profit as a percentage of revenue than non-bulk sales
.
C
ustomers rece
i
ve
l
ower pr
i
c
i
ng on
b
u
lk
sa
l
es o
f
t
h
e same pro
d
ucts t
h
an non-
b
u
lk
sa
l
es
d
ue to vo
l
ume pr
i
c
i
ng
i
n
a
com
p
etitive market and due to lower costs related to the fewer services we
p
rovide. In addition, bulk sales in
a
ggregate generate higher segment cost of products sold as a percentage of revenue than non-bulk sales, because
b
u
lk
or
d
ers cons
i
st
l
arge
l
yo
fhi
g
h
er cost
b
ran
d
e
d
pro
d
ucts. T
h
e
hi
g
h
er segment cost o
f
pro
d
ucts so
ld
as
a
percenta
g
e of revenue for bulk sales is also driven b
y
lower branded manufacturer mar
g
in and manufacturer cas
h
d
iscounts due to the mix of branded products in bulk sales. Segment distribution, selling, general and
ad
m
i
n
i
strat
i
ve (“SG&A”) expenses as a percentage o
f
revenue
f
rom
b
u
lk
sa
l
es are su
b
stant
i
a
ll
y
l
ower t
h
an
f
rom
non-bulk sales because bulk sales require substantiall
y
fewer services to be rendered b
y
us than non-bulk sales
.
3